RDNT Competitors & Alternatives
Compare RadNet Inc with similar stocks in the same industry
Diagnostics & Research
RDNT
Main Stock$55.91
Tradestie Score
59
Market Cap
$6.00B
Revenue Growth
0.2%
Analyst Upside
+60.5%
Top Competitors
38 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BLLN
BLLN
|
$102.98
|
$4.84B | 191.2 | 57 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$15.75
|
$4.60B | 38.6 | 56 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$106.84
|
$3.51B | 24.9 | 59 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$59.30
|
$3.26B | - | 62 | Compare |
|
VCYT
Veracyte, Inc.
|
$53.40
|
$2.85B | 49.7 | 62 | Compare |
|
SGRY
Surgery Partners, Inc. Common Stock
|
$14.41
|
$2.72B | - | 60 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$62.10
|
$2.24B | - | 59 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$17.50
|
$2.22B | - | 59 | Compare |
|
ADUS
Addus HomeCare Corp.
|
$95.48
|
$2.13B | 17.4 | 58 | Compare |
|
LMAT
LeMaitre Vascular, Inc.
|
$91.55
|
$1.96B | 34.5 | 61 | Compare |
More RDNT Analysis
Data updated: Jun 23, 2026 | Industry: Diagnostics & Research (SIC 8071)
38 stocks in this industry